Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity

v3.25.4
Stockholders’ Equity
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders’ Equity

12. Stockholders’ Equity

 

Twin Vee

 

Common Stock Issuance

 

On October 3, 2022, the Company issued and sold to ThinkEquity LLC, as the underwriter in a firm commitment underwritten public offering (the “Offering”) pursuant to the term of an underwriting agreement that the Company entered into with ThinkEquity LLC on September 28, 2022 (the “Underwriting Agreement”),an aggregate of 2,500,000 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $2.75 per share, for gross proceeds of $6,875,000, before deducting underwriting discounts, commissions and offering expenses. Pursuant to the Underwriting Agreement, the Company also issued to the underwriter, warrants to purchase up to 143,750 shares of common stock. The warrants will be exercisable at a per share exercise price of $3.4375.

 

On November 26, 2024, pursuant to the terms of the Merger Agreement with Forza and Merger Sub, Forza merged with and into Merger Sub, with Forza surviving the merger (the “Merger”). The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended. Subject to the terms and conditions of the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each outstanding share of Forza common stock (other than any shares held by us), were converted into the right to receive 0.61166627 shares (the “Exchange Ratio”) of our common stock, any fractional shares to be rounded down to the nearest whole share of common stock, for an aggregate of 5,354,480 shares of our common stock. No cash proceeds were received related to this share issuance.

 

On May 8, 2025, we entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity LLC, as representative of the several underwriters named therein (the “Representative”), pursuant to which we agreed to sell to the Representative in a firm commitment underwritten public offering (the “May 2025 Offering”) an aggregate of 750,000 shares (the “Shares”) of our common stock at the public offering price of $4.00 per share, resulting in gross proceeds of $3.0 million, before deducting underwriting discounts, commissions and offering expenses. The Shares were sold pursuant to an effective shelf registration statement on Form S-3 (File No. 333-266858) filed with the SEC under the Securities Act and declared effective by the Commission on August 24, 2022, a base prospectus, dated August 24, 2022, included in the Registration Statement at the time it originally became effective, and a prospectus supplement, dated May 8, 2025, filed with the Commission pursuant to Rule 424(b) under the Securities Act. Pursuant to the Underwriting Agreement, we also issued to designees of the Representative unregistered warrants to purchase up to 37,500 shares of our common stock, which equals 5% of the shares of common stock purchased in the May 2025 Offering. The May 2025 Offering closed on May 12, 2025. The net proceeds to us from the May 2025 Offering, after deducting the underwriting discount, the Representative’s fees and expenses and our estimated offering expenses, were $2,555,101.

 

Common Stock Warrants

 

Common Stock Warrants

 

As of December 31, 2025 and December 31, 2024, the Company had outstanding warrants to purchase an aggregate of 56,237 shares of common stock:

 

  warrants to purchase 15,000 shares of common stock at an exercise price of $75.00 per share that were issued to the representative of the underwriters on July 23, 2021, in connection with the Company’s IPO. The representative’s warrants are exercisable at any time and from time to time, in whole or in part, and expire on July 20, 2026.

 

  warrants to purchase 14,375 shares of common stock at an exercise price of $34.38 were issued to the representative of the underwriters on October 3, 2022, in connection with an underwritten public offering. These representative’s warrants are exercisable at any time and from time to time, in whole or in part, and expire on September 28, 2027.

 

  warrants to purchase 10,550 shares of common stock at an exercise price of $102.20. These warrants were assumed by the Company on November 26, 2024 in connection with the Merger and were converted into a warrant to purchase the number of shares of Company common stock that the holder would have received if such holder had exercised such warrant to purchase shares of Forza common stock prior to the Merger. These representative’s warrants were originally issued in connection with Forza X1, Inc.’s initial public offering that closed on August 16, 2022, and are exercisable at any time and from time to time, in whole or in part, and expire on August 11, 2027.

 

  warrants to purchase 16,312 shares of common stock at an exercise price of $30.70. These warrants were assumed by the Company on November 26, 2024 in connection with the Merger and were converted into a warrant to purchase the number of shares of Company common stock that the holder would have received if such holder had exercised such warrant to purchase shares of Forza common stock prior to the Merger These representative’s warrants were originally issued in connection with Forza X1, Inc.’s public offering that closed on June 14, 2023, and are exercisable at any time and from time to time, in whole or in part, and expire on June 12, 2028.

 

There was no warrant activity during the years ended December 31, 2025 and 2024.

 

Equity Compensation Plan

 

The Company maintains an equity compensation plan (the “Plan”) under which it may award employees, directors and consultants’ incentive and non-qualified stock options, restricted stock, stock appreciation rights and other stock-based awards with terms established by the Compensation Committee of the Board of Directors which has been appointed by the Board of Directors to administer the Plan. The number of awards under the Plan automatically increases on January 1 of each year. As of December 31, 2025, there were 139,551 shares remaining available for grant under this Plan.

 

Accounting for Stock-Based Compensation

 

Stock Compensation Expense

 

For the year ended December 31, 2025 and 2024, the Company recorded $303,133 and $1,177,140, respectively, of stock-based compensation expense, which is included in salaries and wages on the accompanying consolidated statements of operations.

 

Stock Options

 

Under the Company’s 2021 Stock Incentive Plan the Company has issued stock options. A stock option grant gives the holder the right, but not the obligation to purchase a certain number of shares at a predetermined price for a specific period of time. The Company typically issues options that vest pro rata on a monthly basis over various periods. Under the terms of the Plan, the contractual life of the option grants may not exceed ten years.

 

The Company utilizes the Black-Scholes model to determine fair value of stock option awards on the date of grant. The Company utilized the following assumptions for option grants during the years ended December 31, 2025 and 2024:

 

               
    Year Ended December 31   Year Ended December 31,
    2025   2024
Expected term     5.25.8 years        1.4-6.5 years  
Expected average volatility     48.4% – 49.0%       39.149.6%  
Expected dividend yield            
Risk-free interest rate     4.1 %     3.84.6%  

 

The expected volatility of the option is determined using historical volatilities based on historical stock price of comparable boat manufacturing companies. The Company estimated the expected life of the options granted based upon historical weighted average of comparable boat manufacturing companies. The risk-free interest rate is determined using the U.S. Department of the Treasury yield curve rates with a remaining term equal to the expected life of the option. The Company has never paid a dividend, and as such the dividend yield is 0.0%

 

                                 
    Options Outstanding        
    Number of   Weighted Average   Weighted Average Remaining life   Fair value
    Options   Exercise Price   (years)   of options
                 
Outstanding, January 1, 2024       127,093     $ 39.85       8.04     $ 2,213,178  
Granted       135,236       21.90       6.50       266,495  
Exercised                          
Forfeited/canceled       (48,425 )     (36.34 )           (770,980 )
Outstanding, December 31, 2024       213,904     $ 29.30       8.03     $ 1,708,693  
Granted       72,000       2.71       5.73       98,371  
Exercised                          
Forfeited/canceled       (54,392 )     (7.61 )           (203,632 )
Outstanding, December 31, 2025       231,512     $ 26.13       7.44     $ 1,603,432  
                                   
Exercisable options, December 31, 2025       168,286     $ 34.53       6.80          

 

At December 31, 2025, 63,236 shares of Twin Vee options are unvested and expected to vest over the next four years.

 

Restricted Stock Units

 

Under the Company’s 2021 Stock Incentive Plan the Company has issued restricted stock units (“RSUs”). RSUs are granted with a fair value equal to the closing market price of our common stock on the business day of the grant date. An award may vest completely at a point in time (cliff-vest) or in increments over time (graded-vest). Generally, RSUs vest over three years.

 

                                 
    Restricted Stock Units Outstanding        
    Number of   Weighted Average Grant – Date   Weighted Average Remaining life   Aggregate Intrinsic
    Units   Fair Value Price   (years)   Value
                 
Outstanding, January 1, 2024       6,725     $ 22.50       1.50     $ 11,702  
Granted       8,730       8.38       3.00       15,190  
Exercised                            
Forfeited/canceled       (7,888 )     (13.13 )           (13,725 )
Outstanding, December 31, 2024       7,567     $ 15.98       1.51     $ 13,167  
                                   
Granted       8,900       4.40       2.56       15,486  
Exercised                            
Forfeited/canceled       (3,415 )     (6.86 )           (5,943 )
Outstanding, December 31, 2025       13,052     $ 10.47       1.35     $ 22,710  

 

Wizz Banger, Inc. Stock Options

 

On June 12, 2025, the Company’s wholly owned subsidiary, Wizz Banger, Inc., granted stock options to certain members of its executive team under a newly adopted equity incentive plan. The grant consisted of 2,800,000 options to acquire common shares of the subsidiary at an exercise price of $0.12 per share, which equaled the estimated fair market value of the subsidiary’s common stock on the grant date, as determined by a third-party valuation.

 

The options are subject to 12-month cliff vesting, whereby no portion of the award vests unless the executive remains employed by the subsidiary for the full 12-month period following the grant date. Upon completion of the service period, 100% of the options will vest.

 

The Company is recognizing compensation expense on a straight-line bases over the vesting period. As of December 31, 2025, $102,246 of compensation expense has been recognized. The total grant-date fair value of the award was estimated to be approximately $188,761, calculated using the Black-Scholes option pricing model with the following assumptions:

 

  Expected Term: 6 years

 

  Expected Volatility: 55% (based on comparable SaaS companies)

 

  Risk-Free Interest Rate: 4.2%

 

  Dividend Yield: 0%

 

  Fair Value per Option: $0.0674